DrugPatentWatch Database Preview
J And J Company Profile
What is the competitive landscape for J AND J, and when can generic versions of J AND J drugs launch?
J AND J has thirty-two approved drugs.
There are eight US patents protecting J AND J drugs.
There are one hundred and three patent family members on J AND J drugs in forty-three countries and sixteen supplementary protection certificates in eight countries.
Summary for J And J
| International Patents: | 103 |
| US Patents: | 8 |
| Tradenames: | 25 |
| Ingredients: | 12 |
| NDAs: | 32 |
Drugs and US Patents for J And J
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J And J Consumer Inc | PEPCID COMPLETE | calcium carbonate; famotidine; magnesium hydroxide | TABLET, CHEWABLE;ORAL | 020958-001 | Oct 16, 2000 | OTC | Yes | Yes | 5,989,588*PED | ➤ Sign Up | ➤ Sign Up | ||||
| J And J | PREVACARE R | chlorhexidine gluconate | SOLUTION;TOPICAL | 072292-001 | Jan 28, 1992 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020325-002 | Sep 23, 2003 | OTC | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| J And J Consumer Inc | TYLENOL | acetaminophen | SUPPOSITORY;RECTAL | 017756-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for J And J
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020902-001 | Aug 5, 1999 | 5,854,267*PED | ➤ Sign Up |
| J And J Consumer Inc | PEPCID COMPLETE | calcium carbonate; famotidine; magnesium hydroxide | TABLET, CHEWABLE;ORAL | 020958-001 | Oct 16, 2000 | 5,817,340*PED | ➤ Sign Up |
| J And J Consumer Inc | CHILDREN'S MOTRIN | ibuprofen | TABLET, CHEWABLE;ORAL | 020601-001 | Nov 15, 1996 | 5,215,755*PED | ➤ Sign Up |
| J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020902-001 | Aug 5, 1999 | 4,283,408*PED | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for J AND J drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Syrup | 5 mg/5 mL | ➤ Subscribe | 2007-03-19 |
| ➤ Subscribe | Chewable Tablets | 800 mg/ 10 mg/ 165 mg (OTC) | ➤ Subscribe | 2004-11-01 |
| ➤ Subscribe | Chewable Tablets | 5 mg and 10 mg | ➤ Subscribe | 2005-03-25 |
Non-Orange Book US Patents for J And J
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 7,060,730 | Rapidly absorbed liquid compositions | ➤ Sign Up |
| 6,489,329 | Pharmaceutical compositions for the treatment of rhinitis | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for J And J Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2007176958 | ➤ Sign Up |
| Brazil | 0002607 | ➤ Sign Up |
| Australia | 8201598 | ➤ Sign Up |
| Costa Rica | 7198 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for J And J Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C0004 | France | ➤ Sign Up | PRODUCT NAME: DESLORATADINE; PSEUDOEPHEDRINE SULFATE; REGISTRATION NO/DATE: EU/1/07/399/001 20070730 |
| C/GB98/013 | United Kingdom | ➤ Sign Up | PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923 |
| 01C/045 | Belgium | ➤ Sign Up | PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103 |
| 2014 00050 | Denmark | ➤ Sign Up | PRODUCT NAME: EZETIMIBE AND ATORVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING ATORVASTATIN AS ATORVASTATIN CALCIUM TRIHYDRATE; REG. NO/DATE: DE/H/3895-3898/001-004/DC 20140910 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.
